Protara Therapeutics, Inc. Stock Börse Stuttgart
Stocks
1KPA
US74365U1079
Biotechnology & Medical Research
|
Market Closed -
Börse Stuttgart
15:55:24 2026-08-14 EDT
|
5-day change | 1st Jan Change | ||
| 3.370 EUR | -0.59% |
|
-3.09% | -23.99% |
| 08-11 | Protara Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 06-30 | Protara Therapeutics CMO Leonardo Viana Nicacio Resigns | MT |
| Market Cap | 235M 203M 190M 173M 326M 22.43B 331M 2.23B 872M 11.23B 881M 862M 37.33B | P/E 2026 * |
-2.86x | P/E 2027 * | -2.59x |
|---|---|---|---|---|---|
| Enterprise Value | 235M 203M 190M 173M 326M 22.43B 331M 2.23B 872M 11.23B 881M 862M 37.33B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 235x |
| Free-Float |
97.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Protara Therapeutics, Inc.
| 1 week | -4.37% | ||
| Current month | -0.47% | ||
| 1 month | -5.50% | ||
| 3 months | -25.04% | ||
| 6 months | -37.59% | ||
| Current year | -24.44% |
| 1 week | 3.24 |  | 3.55 |
| 1 month | 3.24 | | 3.66 |
| 3 years | 0.99 | | 9.6 |
| 5 years | 0.99 | | 9.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacqueline Zummo
CTO | Chief Tech/Sci/R&D Officer | 45 | 2019-02-28 |
Jesse Shefferman
CEO | Chief Executive Officer | 54 | 2017-10-31 |
Patrick Fabbio
DFI | Director of Finance/CFO | 58 | 2023-01-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Beshar
CHM | Chairman | 67 | 2019-12-31 |
Richard Levy
BRD | Director/Board Member | 68 | 2019-12-31 |
Gregory Sargen
BRD | Director/Board Member | 60 | 2019-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.59% | -3.09% | +22.99% | +63.59% | 235M | |
| -1.90% | +2.85% | +62.82% | +104.39% | 70.07B | |
| -3.21% | -4.32% | +31.85% | +58.98% | 52.87B | |
| -2.05% | -5.61% | -3.18% | +449.22% | 27.02B | |
| -1.27% | -1.57% | +45.90% | +7.86% | 23.61B | |
| +1.05% | -0.62% | -18.00% | -13.77% | 23.38B | |
| +3.81% | +20.97% | +266.37% | +477.93% | 19.43B | |
| +0.10% | +1.40% | +35.36% | -19.47% | 18.75B | |
| -0.95% | -3.52% | +19.93% | +587.13% | 15.85B | |
| +1.24% | -5.23% | +33.75% | +140.34% | 12.7B | |
| Average | -0.35% | +1.95% | +49.78% | +185.62% | 29.3B | |
| Weighted average by Cap. | -1.09% | +0.55% | +50.21% | +160.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 1M 864K 812K 738K 1.39M 95.62M 1.41M 9.51M 3.72M 47.88M 3.75M 3.67M 159M |
| Net income | -85.87M -74.16M -69.69M -63.38M -119M -8.21B -121M -817M -319M -4.11B -322M -315M -13.66B | -108M -93.14M -87.52M -79.6M -150M -10.31B -152M -1.03B -401M -5.16B -405M -396M -17.16B |
| Net Debt | - | - |
| Date | Price | Change |
|---|---|---|
| 26-08-14 | €3.370 | -0.59% |
| 26-08-13 | €3.390 | +1.74% |
| 26-08-12 | €3.332 | -0.77% |
| 26-08-11 | €3.358 | -4.66% |
| 26-08-10 | €3.522 | -0.06% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TARA Stock
- 1KPA Stock
Select your edition
All financial news and data tailored to specific country editions
